Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: A wireless pH metry analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 1, 2010, Pages 43-47

  Banerjee, Rupa ^a   Reddy, D Nageshwar ^a   Guda, Nalini M ^b   Kalpala, Rakesh ^a   Mahurkar, Swapna ^a   Darisetty, Santosh ^a   Rao, G Venkat ^a  

^a ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bravo pH capsule; Buffered esomeprazole; Immediate release esomeprazole; Intragastric pH; Wireless pH metry

Indexed keywords

ESOMEPRAZOLE; PANTOPRAZOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; HUMAN EXPERIMENT; MALE; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH; TELEMETRY;

EID: 73449138417     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05994.x     Document Type: Article

References (40)

1. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am. J. Gastroenterol. 1995 90 : 206 210.
2. Laine L, Peterson WL. Bleeding peptic ulcer. N. Engl. J. Med. 1994 331 : 717 727.
3. Green FW Jr., Kaplan MM, Curtis LE et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978 74 : 38 43.
4. Patchett SE, Enright H, Afdhal N et al. Clot lysis by gastric juice: an in vitro study. Gut 1989 30 : 1704 1707.
5. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor therapy for peptic ulcer bleeding: cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin. Proc. 2007 82 : 286 296.
6. Bardou M, Toubouti Y, Benhaberou-Brun D et al. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment. Pharmacol. Ther. 2005 21 : 677 686.
7. Lau JYW, Sung JJY, Lee KKC et al. Effects of intravenous omeprazole with recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N. Engl. J. Med. 2000 343 : 310 316.
8. Bajaj JS, Dua KS, Hanson K et al. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Dig. Dis. Sci. 2007 52 : 2190 2194.
9. Howden CW, Forrest JA, Meredith PA et al. Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man. Br. J. Clin. Pharmacol. 1985 20 : 137 139.
10. Leontiadis GI, Sharma VK, Howden CW. Systematic review and metaanalysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ 2005 330 : 568.
11. Howden CW. Review article: immediate-release proton-pump inhibitor therapy - potential advantages. Aliment. Pharmacol. Ther. 2005 22 (Suppl. 3 25 30.
12. Howden CW, Ballard ED, Koch FK et al. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed release proton pump inhibitors in patients with GERD. J. Clin. Gastroenterol. 2009 43 : 323 326.
13. Hepburn B, Goldlust B. Comparative effects of an omeprazole antacid compleximmediate release (OCA-IR) and omeprazole delayed release (OME-DR) on omeprazole pharmacokinetics and gastric pH in healthy subjects. Gastroenterology 2003 124 : A228.
14. Castell D, Bagin R, Goldlust B, Major J, Hepburn B. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2005 21 : 1467 1474.
15. Package insert (Nexprofast): Torrent Pharmaceuticals Limited, Ahmedabad (India).
16. Banerjee R, Reddy DN. Endoscopy-assisted wireless intragastric pH monitoring. Gastrointest. Endosc. 2007 65 : 182.
17. Banerjee R, Reddy DN. Bravo capsule pH monitoring. Am. J. Gastroenterol. 2006 101 : 906.
18. Banerjee R, Lakhtakia S, Tandon M et al. Endoscopy-Assisted Wireless Intragastric pH Measurement. Endoscopy 2005 37 : 922.
19. Yamaguchi T, Seza A, Odaka T et al. Placement of the Bravo wireless pH monitoring capsule onto the gastric wall under endoscopic guidance. Gastrointest. Endosc. 2006 63 : 1046 1050.
20. Pandolfino JE, Schreiner MA, Lee TJ et al. Bravo capsule placement in the gastric cardia: a novel method for analysis of proximal stomach acid environment. Am. J. Gastroenterol. 2005 100 : 1721 1727.
21. SPSS for Windows. Rel. 13.0. 2004. Chicago, IL : SPSS.
22. Lau JY, Leung WK, Wu JC et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N. Engl. J. Med. 2007 356 : 1631 1640.
23. Tuynman HA, Festen HP, Rohss K et al. Lack of effect of antacids on plasma concentrations of omeprazole given as enteric-coated granules. Br. J. Clin. Pharmacol. 1987 24 : 833 835.
24. Yasuda S, Higashi S, Murakami M et al. Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers. Int. J. Clin. Pharmacol. Ther. 1999 37 : 249 253.
25. Katz PO, Koch FK, Ballard ED et al. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Aliment. Pharmacol. Ther. 2007 25 : 197 205.
26. Wilder-Smith CH, Rohss K, Bondarov P et al. Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study. Aliment. Pharmacol. Ther 2004 20 : 1099 1104. (Pubitemid 39657943)
27. Armstrong D, James C, Camacho F et al. Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Aliment. Pharmacol. Ther. 2007 25 : 185 196.
28. Armstrong D, Bair D, James C et al. Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Aliment. Pharmacol. Ther. 2003 18 : 705 711.
29. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay - results from the Cochrane Collaboration. Aliment. Pharmacol. Ther. 2005 22 : 169 174.
30. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N. Engl. J. Med. 2008 359 : 928 937.
31. Metz DC, Amer F, Hunt B et al. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages. Aliment. Pharmacol. Ther. 2006 23 : 985 995.
32. Khuroo MS, Yattoo GN, Javid G et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N. Engl. J. Med. 1997 336 : 1054 1058.
33. Javid G, Masoodi I, Zargar SA et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am. J. Med. 2001 111 : 280 284.
34. Spiegel BM, Dulai GS, Lim BS et al. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. Clin. Gastroenterol. Hepatol. 2006 4 : 988 997.
35. Al-Sabah S, Barkun AN, Herba K et al. Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. Clin. Gastroenterol. Hepatol. 2008 6 : 418 425.
36. Tsoi KK, Lau JY, Sung JJ. Cost-effectiveness analysis of high dose omeprazole infusion before endoscopy for patients with upper GI bleeding. Gastrointest. Endosc. 2008 67 : 1056 1063.
37. Chang JH, Choi MG, Yim DS et al. A novel placement method of the bravo wireless pH monitoring capsule for measuring intragastric pH. Dig. Dis. Sci. 2009 54 : 578 585.
38. Van Rensburg CJ, Hartmann M, Thorpe A et al. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am. J. Gastroenterol. 2003 98 : 2635 2641.
39. Brunner G, Luna P, Hartmann M et al. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J. Biol. Med. 1996 69 : 225 231.
40. Banerjee R, Reddy DN, Rao GV et al. Oral Buffered Esomeprazole (BE) in twice daily doses can maintain a sustained pH > 6 in patients with Acute Non Variceal Bleed (ANVB) after endotherapy: a clinical trial with continuous intragastric pH monitoring. Presented DDW 2008, San Diego, CA.